Use Able AI chat for product recommendations

Phospho-Ezrin (Tyr354) Recombinant monoclonal antibody, PBS Only

Phospho-Ezrin (Tyr354) Uni-rAb® Recombinant Antibody for WB, Indirect ELISA

Cat No. 88246-2-PBS
Clone No.260442B10

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

WB, Indirect ELISA

Ezrin (Tyr353), Ezrin (Tyr354), p-Ezrin, p-Ezrin (Tyr353), p-Ezrin (Tyr354)

Formulation:  PBS Only
Conjugate:  Unconjugated
Size/Concentration: 
SKU: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:


Product Information

88246-2-PBS targets Phospho-Ezrin (Tyr354) in WB, Indirect ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Host / Isotype Rabbit / IgG
Class Recombinant
Type Antibody
Immunogen

Peptide

Predict reactive species
Full Name ezrin
Calculated Molecular Weight69 kDa
Observed Molecular Weight80 kDa
GenBank Accession NumberNM_001111077
Gene Symbol Ezrin
Gene ID (NCBI) 7430
ENSEMBL Gene IDENSG00000092820
Conjugate Unconjugated
FormLiquid
Purification MethodProtein A purification
UNIPROT IDP15311
Storage Buffer PBS only, pH 7.3.
Storage ConditionsStore at -80°C.

Background Information

Ezrin is a member of the ERM (Ezrin, Radixin, Moesin) protein family and serves as a crucial linker between the cell membrane and the actin cytoskeleton. Phospho-Ezrin (Tyr354), also annotated as Tyr353 in early literature, is a tyrosine-phosphorylated active form of ERM scaffold protein Ezrin encoded by the EZR gene. Triggered by HGF receptor tyrosine kinase, this modification unlocks Ezrin's autoinhibited conformation and enables high-affinity binding to the p85 regulatory subunit of PI3K. It sustains PI3K/Akt survival signaling, suppresses epithelial apoptosis, and drives cytoskeleton remodeling for cell migration and tubulogenesis. Unique from Thr567-phosphorylated Ezrin at cell membranes, p-Ezrin (Tyr354) translocates into nuclei in osteosarcoma and lung cancer. Its elevated nuclear expression correlates with tumor invasion, metastasis, and poor clinical prognosis, marking it a promising malignant progression biomarker. (PMID: 10377409, 20348881)

Loading...
||
New chat

Able

正在加载,请稍候...